Prince Pipes and Fittings Limited (NSE:PRINCEPIPE)
India · Delayed Price · Currency is INR 336.10
-0.95 (-0.28%)
Aug 1, 2025, 3:30 PM IST
CTI BioPharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 25,239 | 25,687 | 27,109 | 26,568 | 20,715 | Upgrade | |
Revenue Growth (YoY) | -1.75% | -5.24% | 2.03% | 28.26% | 26.65% | Upgrade |
Cost of Revenue | 18,839 | 18,303 | 21,030 | 18,915 | 13,789 | Upgrade |
Gross Profit | 6,400 | 7,385 | 6,079 | 7,653 | 6,927 | Upgrade |
Selling, General & Admin | 1,742 | 2,085 | 1,611 | 1,621 | 1,707 | Upgrade |
Other Operating Expenses | 3,040 | 2,228 | 1,968 | 1,841 | 1,538 | Upgrade |
Operating Expenses | 5,852 | 5,224 | 4,408 | 4,165 | 3,839 | Upgrade |
Operating Income | 547.76 | 2,161 | 1,670 | 3,489 | 3,088 | Upgrade |
Interest Expense | -96.73 | -48.73 | -102.4 | -122.82 | -181.14 | Upgrade |
Interest & Investment Income | - | 64.54 | 47.67 | 45.68 | 158.63 | Upgrade |
Currency Exchange Gain (Loss) | - | 33.04 | 6.11 | -25.56 | -33.24 | Upgrade |
Other Non Operating Income (Expenses) | 137.45 | -15.17 | -6.51 | -14.39 | -25.53 | Upgrade |
EBT Excluding Unusual Items | 588.48 | 2,195 | 1,615 | 3,372 | 3,007 | Upgrade |
Gain (Loss) on Sale of Investments | - | 55.42 | 30.72 | 3.92 | 7.5 | Upgrade |
Gain (Loss) on Sale of Assets | - | 8.22 | 2.46 | -6.82 | -22.74 | Upgrade |
Legal Settlements | - | 179.23 | - | - | - | Upgrade |
Other Unusual Items | - | 0.04 | - | - | - | Upgrade |
Pretax Income | 588.48 | 2,438 | 1,648 | 3,369 | 2,991 | Upgrade |
Income Tax Expense | 157.12 | 612.72 | 434.2 | 874.68 | 773.16 | Upgrade |
Net Income | 431.36 | 1,825 | 1,214 | 2,494 | 2,218 | Upgrade |
Net Income to Common | 431.36 | 1,825 | 1,214 | 2,494 | 2,218 | Upgrade |
Net Income Growth | -76.36% | 50.30% | -51.31% | 12.43% | 97.17% | Upgrade |
Shares Outstanding (Basic) | 111 | 111 | 111 | 110 | 110 | Upgrade |
Shares Outstanding (Diluted) | 111 | 111 | 111 | 110 | 110 | Upgrade |
Shares Change (YoY) | 0.04% | - | 0.29% | 0.14% | 15.15% | Upgrade |
EPS (Basic) | 3.90 | 16.51 | 10.98 | 22.62 | 20.16 | Upgrade |
EPS (Diluted) | 3.90 | 16.51 | 10.98 | 22.62 | 20.15 | Upgrade |
EPS Growth | -76.37% | 50.33% | -51.46% | 12.26% | 71.22% | Upgrade |
Free Cash Flow | -1,367 | -1,544 | 2,699 | -1,887 | 1,702 | Upgrade |
Free Cash Flow Per Share | -12.36 | -13.96 | 24.41 | -17.12 | 15.46 | Upgrade |
Dividend Per Share | 0.500 | 1.000 | - | 3.500 | 3.500 | Upgrade |
Dividend Growth | -50.00% | - | - | - | 250.00% | Upgrade |
Gross Margin | 25.36% | 28.75% | 22.42% | 28.81% | 33.44% | Upgrade |
Operating Margin | 2.17% | 8.41% | 6.16% | 13.13% | 14.91% | Upgrade |
Profit Margin | 1.71% | 7.11% | 4.48% | 9.39% | 10.71% | Upgrade |
Free Cash Flow Margin | -5.42% | -6.01% | 9.96% | -7.10% | 8.22% | Upgrade |
EBITDA | 1,618 | 3,027 | 2,470 | 4,168 | 3,660 | Upgrade |
EBITDA Margin | 6.41% | 11.79% | 9.11% | 15.69% | 17.67% | Upgrade |
D&A For EBITDA | 1,070 | 866.23 | 799.56 | 678.9 | 572.4 | Upgrade |
EBIT | 547.76 | 2,161 | 1,670 | 3,489 | 3,088 | Upgrade |
EBIT Margin | 2.17% | 8.41% | 6.16% | 13.13% | 14.91% | Upgrade |
Effective Tax Rate | 26.70% | 25.14% | 26.34% | 25.96% | 25.85% | Upgrade |
Revenue as Reported | 25,377 | 25,848 | 27,194 | 26,623 | 20,891 | Upgrade |
Advertising Expenses | - | 544.31 | 413.86 | 415.21 | 657.17 | Upgrade |
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.